Cholinesterase inhibitors and adverse pulmonary events in older people with chronic obstructive pulmonary disease and concomitant dementia: A population-based, cohort study

Drugs and Aging

Volumn 29, Issue 3, 2012, Pages 213-223

  Stephenson, Anne ^a,b   Seitz, Dallas P ^c   Fischer, Hadas D ^d   Gruneir, Andrea ^a,d,e   Bell, Chaim M ^b,d,e,f   Gershon, Andrea S ^d,e   Fu, Longdi ^d   Anderson, Geoff M ^a,d,e   Austin, Peter C ^d   Rochon, Paula A ^a,d,e,f   Gill, Sudeep S ^c  

^a WOMEN S COLLEGE HOSPITAL   (Canada)

^b ST MICHAEL'S HOSPITAL   (Canada)

^c QUEEN S UNIVERSITY   (Canada)

^d INSTITUTE FOR CLINICAL EVALUATIVE SCIENCES   (Canada)

^e UNIVERSITY OF TORONTO   (Canada)

^f UNIVERSITY OF TORONTO   (Canada)

Author keywords

Adverse drug reactions; Cholinesterase inhibitors; Chronic obstructive pulmonary disease; Dementia; Elderly.

Indexed keywords

DONEPEZIL; GALANTAMINE; RIVASTIGMINE;

AGED; ARTICLE; CANADA; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMORBIDITY; CONTROLLED STUDY; DEMENTIA; DISEASE SEVERITY; DRUG SAFETY; ELDERLY CARE; EMERGENCY WARD; FEMALE; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK FACTOR;

AGED; AGED, 80 AND OVER; CHOLINESTERASE INHIBITORS; COHORT STUDIES; DATABASES, FACTUAL; DEMENTIA; DRUG PRESCRIPTIONS; ELECTRONIC HEALTH RECORDS; FEMALE; HOSPITALIZATION; HUMANS; MALE; NOOTROPIC AGENTS; ONTARIO; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; PULMONARY VENTILATION; RESPIRATORY TRACT DISEASES; RETROSPECTIVE STUDIES; RISK FACTORS; SEVERITY OF ILLNESS INDEX;

EID: 84857810582     PISSN: 1170229X     EISSN: 11791969     Source Type: Journal    
DOI: 10.2165/11599480-000000000-00000     Document Type: Article

References (31)

1. Ballard C, Gauthier S, Corbett A, et al. Alzheimer s disease. Lancet 2011; 377 (9770): 1019-31
2. Hogan D, Bailey P, Black S, et al. Diagnosis and treatment of dementia: 5. Nonpharmacologic and pharmacologic therapy for mild to moderate dementia. CMAJ 2008; 179 (10): 1019-26
3. Gill SS, Bronskill SE, Mamdani M, et al. Representation of patients with dementia in clinical trials of donepezil. Can J Clin Pharmacol 2004; 11 (2): E274-85
4. Mitchell SL, Teno JM, Kiely DK, et al. The clinical course of advanced dementia. N Engl J Med 2009 Oct 15; 361 (16): 1529-38
5. Rochon PA, Berger PB, Gordon M. The evolution of clinical trials: Inclusion and representation. CMAJ 1998 Dec 1; 159 (11): 1373-4
6. Birks J. Cholinesterase inhibitors for Alzheimer s disease. Cochrane Database Syst Rev 2006; (1): CD005593
7. Thacker EL, Schneeweiss S. Initiation of acetylcholinesterase inhibitors and complications of chronic airways disorders in elderly patients. Drug Saf 2006; 29 (11): 1077-85
8. Gershon AS, Wang C, Guan J, et al. Identifying individuals with physician diagnosed COPD in health administrative databases. COPD 2009 Oct; 6 (5): 388-94
9. Levy AR, O Brien BJ, Sellors C, et al. Coding accuracy of administrative drug claims in the Ontario Drug Benefit database. Can J Clin Pharmacol 2003; 10 (2): 67-71
10. Gill SS, Bronskill SE, Normand SL, et al. Antipsychotic drug use and mortality in older adults with dementia. Ann Intern Med 2007 Jun 5; 146 (11): 775-86
11. Gill SS, Anderson GM, Fischer HD, et al. Syncope and its consequences in patients with dementia receiving cholinesterase inhibitors: A population-based cohort study. Arch Intern Med 2009 May 11; 169 (9): 867-73
12. Rochon PA, Normand SL, Gomes T, et al. Antipsychotic therapy and short-term serious events in older adults with dementia. Arch Intern Med 2008; 168 (10): 1090-6
13. Austin P. Statistical criteria for selecting the optimal number of untreated subjects matched to each treated subject when using many-to-one matching on the propensity score. Am J Epidemiol 2010; 172 (9): 1092-7
14. Rosenbaum P, RubinD. Constructing a control group using multivariate matched sampling methods that incorporate the propensity score. Am Stat 1985; 39 (1): 33-8
15. D Agostino R. Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group. Stat Med 1998; 17 (19): 2265-81
16. Stukel T, Fisher E, Wennberg D, et al. Analysis of observation studies in the presence of treatment selection bias: Effects of invasive cardiac management on AMI survival using propensity score and instrumental variable methods. JAMA 2007; 297 (3): 278-85
17. Austin P, Grootendorst P, Anderson G. A comparison of the ability of different propensity score models to balance measured variables between treated and untreated subjects: A Monte Carlo study. Stat Med 2007; 26 (4): 734-53
18. Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol 1992; 45 (6): 613-9
19. Austin P. Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity- score matched samples. Stat Med 2009; 28 (25): 3083-107
20. Mamdani M, Sykora K, Li P, et al. Reader s guide to critical appraisal of cohort studies: 2. Assessing potential for confounding. BMJ 2005 Apr 23; 330 (7497): 960-2
21. Austin P. Optimal caliper widths for propensity-score matching when estimating differences in means and differences in proportions in observational studies. Pharm Stat 2011; 10 (2): 150-61
22. Akazawa M, Stearns SC, Biddle AK. Assessing treatment effects of inhaled corticosteroids on medical expenses and exacerbations among COPD patients: Longitudinal analysis of managed care claims. Health Serv Res 2008; 43 (6): 2164-82
23. Burge S, Wedzicha J. COPD exacerbations: Definitions and classifications. Eur Respir J 2003; 41 Suppl.: 46s-53s
24. Donaldson GC, Hurst JR, Smith CJ, et al. Increased risk of myocardial infarction and stroke following exacerbation of COPD. Chest 2010; 137 (5): 1091-7
25. Gruneir A, Anderson GM, Rochon PA, et al. Transitions in long-term care and potential implications for quality reporting in Ontario, Canada. J Am Med Dir Assoc 2010 Nov; 11 (9): 629-35
26. Gruneir A, Bell CM, Bronskill SE, et al. Frequency and pattern of emergency department visits by long-term care residents: A population-based study. J AmGeriatr Soc 2010 Mar; 58 (3): 510-7
27. Austin P. Comparing paired vs non-paired statistical methods of analyses when making inferences about absolute risk reductions in propensity-score matched samples. Stat Med 2011; 30 (11): 1292
28. Austin P, Laupacis A. A tutorial on methods to estimating clinically and policy-meaningful measures of treatment effects in prospective observational studies: A review. Int J Biostat 2011; 7 (1): Article 6
29. Shepherd G, Klein-Schwartz W, Edwards R. Donepezil overdose: A tenfold dosing error. Ann Pharmacother 1999; 33 (7): 812-5
30. Greene Y, Noviasky J, Tariot P. Donepezil overdose. J Clin Psych 1999; 60 (1): 56-7
31. Liggett SB, Daughaday CC, Senior RM. Ipratropium in patients with COPD receiving cholinesterase inhibitors. Chest 1988 Jul; 94 (1): 210-2